Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Genzyme Molecular Oncology announces initiation of breast cancer vaccine trial

Sep. 16, 1999

Transgene commences phase I trial for treatment of cervical cancer

Sep. 14, 1999

Maxamine treatment leads to tumor regression in preclinical model of prostate cancer

Sep. 14, 1999

LifeTime and Arkios enter oncology alliance

Sep. 13, 1999

Biomira revises collaboration with Chiron for Theratope vaccine

Sep. 7, 1999

Beta LT demonstrates positive results in initial human trials

Sep. 7, 1999

First patient enrolled in York Medical's cancer vaccine trial

Sep. 6, 1999

Immunomedics awarded four grants from the NIH for development of cancer therapies

Sep. 6, 1999

Maxamine combination treatment for AML effective in phase II studies

Sep. 6, 1999

FDA requests modifications to Bexxar BLA

Aug. 31, 1999

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...